SOTERA HEALTH COMPANY Depreciation
SOTERA HEALTH COMPANY (SHC) reported Depreciation of $53.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- SOTERA HEALTH COMPANY depreciation for the quarter ending 2026-06-30 was $27.83M, a 20.53% increase year-over-year.
- SOTERA HEALTH COMPANY depreciation for the quarter ending 2026-03-31 was $25.21M, a 13.93% increase year-over-year.
- SOTERA HEALTH COMPANY depreciation for the quarter ending 2025-12-31 was $26.97M, a 30.49% increase year-over-year.
- SOTERA HEALTH COMPANY depreciation for the quarter ending 2025-09-30 was $22.71M, a 2.14% decline year-over-year.
- SOTERA HEALTH COMPANY depreciation for fiscal 2025 was $94.91M, a 12.64% increase from fiscal 2024.
- SOTERA HEALTH COMPANY depreciation for fiscal 2024 was $84.26M, a 10.03% increase from fiscal 2023.
- SOTERA HEALTH COMPANY depreciation for fiscal 2023 was $76.58M, a 19.65% increase from fiscal 2022.
- SOTERA HEALTH COMPANY depreciation for fiscal 2022 was $64.00M, a 0.25% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $53.05M 10-Q · filed 2026-08-06 | $80.02M derived: sum of 3 quarters · filed 2026-08-06 | $102.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $25.21M 10-Q · filed 2026-05-05 | $52.19M derived: sum of 2 quarters · filed 2026-05-05 | $74.90M derived: sum of 3 quarters · filed 2026-05-05 | $97.99M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $26.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $49.69M derived: sum of 2 quarters · filed 2026-02-24 | $72.78M derived: sum of 3 quarters · filed 2026-08-06 | $94.91M 10-K · filed 2026-02-24 |
| 2025-09-30 | $22.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $45.80M derived: sum of 2 quarters · filed 2026-08-06 | $67.93M 10-Q · filed 2025-11-04 | $88.61M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $23.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $45.22M 10-Q · filed 2026-08-06 | $65.89M derived: sum of 3 quarters · filed 2026-08-06 | $89.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $22.13M 10-Q · filed 2026-05-05 | $42.80M derived: sum of 2 quarters · filed 2026-05-05 | $66.01M derived: sum of 3 quarters · filed 2026-05-05 | $86.08M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $20.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $43.88M derived: sum of 2 quarters · filed 2026-02-24 | $63.95M derived: sum of 3 quarters · filed 2026-02-24 | $84.26M 10-K · filed 2026-02-24 |
| 2024-09-30 | $23.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $43.28M derived: sum of 2 quarters · filed 2025-11-04 | $63.59M 10-Q · filed 2025-11-04 | $84.25M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $20.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $40.38M 10-Q · filed 2025-08-08 | $61.05M derived: sum of 3 quarters · filed 2026-02-24 | $79.04M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $20.31M 10-Q · filed 2025-05-01 | $40.97M derived: sum of 2 quarters · filed 2026-02-24 | $58.96M derived: sum of 3 quarters · filed 2026-02-24 | $77.95M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $20.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $38.66M derived: sum of 2 quarters · filed 2026-02-24 | $57.65M derived: sum of 3 quarters · filed 2026-02-24 | $76.58M 10-K · filed 2026-02-24 |
| 2023-09-30 | $17.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $36.98M derived: sum of 2 quarters · filed 2024-11-05 | $55.91M 10-Q · filed 2024-11-05 | $72.42M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $18.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $37.92M 10-Q · filed 2024-08-05 | $54.42M derived: sum of 3 quarters · filed 2025-02-27 | $70.31M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $18.93M 10-Q · filed 2024-05-02 | $35.44M derived: sum of 2 quarters · filed 2025-02-27 | $51.32M derived: sum of 3 quarters · filed 2025-02-27 | $67.06M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $16.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $32.39M derived: sum of 2 quarters · filed 2025-02-27 | $48.13M derived: sum of 3 quarters · filed 2025-02-27 | $64.00M 10-K · filed 2025-02-27 |
| 2022-09-30 | $15.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $31.63M derived: sum of 2 quarters · filed 2023-11-01 | $47.50M 10-Q · filed 2023-11-01 | $64.20M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $15.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $31.61M 10-Q · filed 2023-08-03 | $48.31M derived: sum of 3 quarters · filed 2024-02-27 | $64.71M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $15.87M 10-Q · filed 2023-05-03 | $32.57M derived: sum of 2 quarters · filed 2024-02-27 | $48.97M derived: sum of 3 quarters · filed 2024-02-27 | $64.65M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $16.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $33.10M derived: sum of 2 quarters · filed 2024-02-27 | $48.78M derived: sum of 3 quarters · filed 2024-02-27 | $64.16M 10-K · filed 2024-02-27 |
| 2021-09-30 | $16.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $32.08M derived: sum of 2 quarters · filed 2022-11-02 | $47.46M 10-Q · filed 2022-11-02 | $63.43M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $15.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $31.06M 10-Q · filed 2022-08-04 | $47.04M derived: sum of 3 quarters · filed 2023-02-28 | $62.94M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $15.38M 10-Q · filed 2022-05-05 | $31.35M derived: sum of 2 quarters · filed 2023-02-28 | $47.26M derived: sum of 3 quarters · filed 2023-02-28 | $62.58M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $15.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $31.88M derived: sum of 2 quarters · filed 2023-02-28 | $47.20M derived: sum of 3 quarters · filed 2023-02-28 | $63.31M 10-K · filed 2023-02-28 |
| 2020-09-30 | $15.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $31.22M derived: sum of 2 quarters · filed 2021-11-10 | $47.33M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $15.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $31.43M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $16.11M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $66.67M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |